Skip to main content
Clinical Trials/NCT03789448
NCT03789448CompletedNot Applicable

MaxART: The Effect of Early Access to ART for All in Swaziland on Economic Outcomes

Till Bärnighausen0 sites3,019 target enrollmentStarted: September 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
3,019
Primary Endpoint
Total healthcare expenditures (for hospitalization and primary care)

Study Overview

Brief Summary

The purpose of this study is to evaluate the impact of offering early antiretroviral therapy to HIV-positive individuals in government-managed health facilities in Swaziland on a range of economic outcomes

Detailed Description

The MaxART study is a three-year stepped-wedge randomized trial with open enrollment for all adults 18 years and older across 14 rural health facilities in Swaziland's Hhohho Region. The main trial registration is accessible at: https://clinicaltrials.gov/ct2/show/record/NCT02909218.

This registration is specific to the economic evaluation of the MaxART study which aims to quantify the causal impacts of early ART initiation (compared to national standard care) on a range of key economic outcomes, including healthcare expenditures, productivity, and household wealth.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Sequential
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All HIV-positive individuals who are aged 18 years or older, are ART naïve and attend the health facilities included in the study

Exclusion Criteria

  • All HIV-positive individuals who are <18 years of age
  • All HIV-positive pregnant or breastfeeding women
  • All HIV-positive individuals who did not consent to participate

Arms & Interventions

National HIV Treatment Guidelines

No Intervention

HIV-positive individuals are offered ART per Swaziland's national treatment guidelines

Early Access to ART for All

Experimental

HIV-positive individuals who are aged 18 years or older are initiated on ART regardless of client's immunological and clinical staging (excluding pregnant or breastfeeding women)

Intervention: Early Access to ART for All (Other)

Outcomes

Primary Outcomes

Total healthcare expenditures (for hospitalization and primary care)

Time Frame: 12 months

Including direct health care costs (e.g., surgery, medication, consultation) and indirect costs (e.g., transport to clinic, payment for someone to look after children, salary lost for time off...)

Total productivity hours

Time Frame: 24 hours

Total Hours per day spent on income generation activities

Secondary Outcomes

  • Household Assets Ownership and Living Standards Index(At study completion, an average of 1.5 years)
  • Rate of participants with current employment(At study completion, an average of 1.5 years)
  • Total sum of self-reported monthly expenditures of the participant's household(12 months)

Investigators

Sponsor
Till Bärnighausen
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Till Bärnighausen

University Hospital Heidelberg

University Hospital Heidelberg

Similar Trials